Activated-protein-c resistance in cancer patients

Pathophysiology of Haemostasis and Thrombosis

Volumn 27, Issue 3, 1997, Pages 112-118

  Green, David ^a   Maliekel, Kochurani ^a   Sushko, Elena ^a   Akhtar, Rasheed ^a   Soff, Gerald A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cancer; Factor V Leiden; Hypercoagulability; Protein C; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; FEMALE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; MALE; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTHROMBIN TIME; THROMBOEMBOLISM; THROMBOSIS;

AGED; AGED, 80 AND OVER; ANTITHROMBIN III; BLOOD COAGULATION; DRUG RESISTANCE, NEOPLASM; FACTOR V; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PROTEIN C; PROTEIN S; VON WILLEBRAND FACTOR;

EID: 0030798772     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217442     Document Type: Article

References (25)

1. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad SciUSA 1993;90:1004-1008.
2. Bertina RM, Koeleman BPC, Roster T, Rosendaal FR. Dirven RJ, Ronde H, van dcr Velden PA, Reits-ma PW: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
3. Zoller B, Svensson PJ, He X, Dahlback B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994;94: 2521-2524.
4. Cumming AM, Tait RC, Fildcs S, Yoong A, Keeney S, Hay CR: Development of resistance to activated protein C during pregnancy. Br J Haematol 1995;90:725-727.
5. Fisher M, Fernandez JA, Ameriso SF, Xie D, Gruber A, Paganini-Hill A, Griffin JH: Activated protein C resistance in ischemic stroke not due to factor V arginine506-α-glutamine mutation. Stroke 1996;27:1163-1166.
6. Rickies FR, Levine M, Edwards RL: Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992: 11:237-248.
7. Sirridgc MS, Shannon R: Laboratory evaluation of hemostasis and thrombosis, ed 3. Philadelphia, Lea & Febiger, 1983, pp 164-165.
8. Batlle J, Lopez-Fernandez MF: Laboratory assays for von Willebrand factor; in Zimmerman TS, Ruggeri ZM (ed): Coagulation and bleeding disorders. New York, Dekker, 1989, pp 330-331.
9. Pelzer H, Schwarz A, Stuber W: Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991;65: 153-159.
10. Edwards RL, Rickies FR: Thrombosis and cancer; in Hull R, Pinco GF (eds): Disorders of Thrombosis. Philadelphia, Saunders, 1996, pp 374-382.
11. Myers TJ, Rickies FR, Barb C, Cronlund M: Activation of blood coagulation in acute leukemia-fibri-nopeptide A (FPA) generation as an indicator of disease activity. Blood 1981;57:518-525.
12. Iversen LH, Okholm M, Thoriacius-Ussing O: Pre-and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease-a preliminary study. Thromb Haemost 1996;76:523-528.
13. 506 to Gin mutation in the factor V gene, and venous thrombosis. Thromb Haemost 1995;73:739-742.
14. Baker R, Thorn J, van BockxmecrF: Diagnosis of activated protein C resistance (factor V Leiden) (letter). Lancet 1994;344:1162.
15. Trossaert M, Conard J, Horellou MH, Samama MM: Influence of storage conditions on activated protein C resistance assay (letter). Thromb Haemost 1995;73:163-164.
16. Legnani C, Palareti G, Biagi R, Coc-cheri S: Evaluation of activated protein C resistance in stored plasma (letter). Lancet 1994;343:1289.
17. Rosendaal FR, Bertina RM, Reits-ma PH: Evaluation of activated protein C resistance in stored plasma. Lancet 1994;343:1289-1290.
18. Martorell JR, Munoz-Castillo A, Gil JL: False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract (letter). Thromb Haemost 1995;74:796-797.
19. Ehrenforth S, Radtke KP, Scharrer I: Acquired activated protein C-re-sistance in patients with lupus anticoagulants (letter). Thromb Haemost 1995;74:797-798.
20. Trossaert M, Conard J, Horellou MH, Samama MM, Ireland H, Bayston TA, Lane DA: Modified APC resistance assay for patients on oral anticoagulants (letter). Lancet 1994;344:1709.
21. Edson JR, Krivit W, White JG: Kaolin partial thromboplastin time: High levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants. J Lab Clin Med 1967;70: 463-470.
22. Lctsky EA, de Swiet M: Maternal hemostasis: Coagulation problems of pregnancy: in Loscalzo L, Schafer AI (eds): Thrombosis and Hemorrhage. Boston, Blackwell, 1994, pp 965-998.
23. Colucci M, Ciavarclla N, Giliberti MG, Semeraro N: Resistance to activated protein C (APC): Influence of factor V levels (letter). Thromb Haemost 1994;72:987-988.
24. de Ronde H, Bertina RM: Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994:72:880-886.
25. Dahlback B: Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995:85: 607-614.